Using single-isomer octa(6-O-sulfo)-γ-cyclodextrin for fast capillary zone electrophoretic enantioseparation of pindolol: Determination of complexation constants, software-assisted optimization, and method validation
Language English Country Netherlands Media print-electronic
Document type Journal Article, Validation Study
PubMed
30122164
DOI
10.1016/j.chroma.2018.07.020
PII: S0021-9673(18)30862-8
Knihovny.cz E-resources
- Keywords
- Capillary electrophoresis, Enantioseparation, Method validation, Pindolol, Single-isomer cyclodextrin, β-blockers,
- MeSH
- Time Factors MeSH
- Electrophoresis, Capillary methods MeSH
- gamma-Cyclodextrins chemistry MeSH
- Calibration MeSH
- Hydrogen-Ion Concentration MeSH
- Limit of Detection MeSH
- Pindolol isolation & purification MeSH
- Buffers MeSH
- Reproducibility of Results MeSH
- Software * MeSH
- Stereoisomerism MeSH
- Publication type
- Journal Article MeSH
- Validation Study MeSH
- Names of Substances
- gamma-Cyclodextrins MeSH
- gamma-cyclodextrin MeSH Browser
- Pindolol MeSH
- Buffers MeSH
The present study describes a rapid and effective capillary electrophoresis (CE) method for the enantioseparation of pindolol using single-isomer octa(6-O-sulfo)-γ-cyclodextrin. The complexation parameters were determined under neutral and high pH conditions to identify optimal separation conditions using a theoretical model. Baseline separation of pindolol enantiomers was achieved within 6 min in a sodium/MOPS buffer, pH 7.2, with a selector concentration of 6 mM. The method was validated according to the ICH guidelines using imidazole as an internal standard. Low limits of detection and quantification were found, specifically 1.2 μg/mL and 4 μg/mL (0.6 μg/mL and 2 μg/mL per enantiomer), respectively. The calibration curves showed good linearity, with a coefficient of determination R2 ≥ 0.999 over a 5 - 55 μg/mL concentration range and over a 50 - 300 μg/mL concentration range of the racemic mixture. The relative standard deviations (%RSD) of intra-day and inter-day precision were lower than 8% at LOQ level, lower than 3% at 50 μg/mL level and lower than 1.5% at 300 μg/mL level. Accuracy ranged from 95 to 103% (106% at LOQ level). The proposed method was successfully tested on a medical formulation of Visken® Sandoz intravenous solution and Visken® Teofarma pills for oral use.
References provided by Crossref.org